SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Homology Medicines Q1 EPS $(0.780) Down From $(0.640) YoY, Sales $588.000K Up From $270.000K YoY

Homology Medicines (NASDAQ:FIXX) reported quarterly losses of $(0.780) per share. This is a 21.88 percent decrease over losses of $(0.640) per share from the same period last year. The company reported $588.000 thousand

Benzinga · 05/07/2020 20:23

Homology Medicines (NASDAQ:FIXX) reported quarterly losses of $(0.780) per share. This is a 21.88 percent decrease over losses of $(0.640) per share from the same period last year. The company reported $588.000 thousand in sales this quarter. This is a 117.78 percent increase over sales of $270.000 thousand the same period last year.